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In the bacterial degradation of polycyclic aromatic hydrocarbons (PAHs), salicylate 3 
hydroxylases catalyze essential reactions at the junction between the so-called upper and 4 
lower catabolic pathways. Unlike the salicylate 1-hydroxylase from pseudomonads, which is 5 
a well-characterized flavoprotein, the enzyme found in sphingomonads appears to be a three-6 
component Fe-S protein complex, which has not so far been characterized. Here, the 7 
salicylate 1-hydroxylase from Sphingomonas CHY-1 has been purified and characterized with 8 
respect to  its biochemical and catalytic properties. The oxygenase component called PhnII, 9 
exhibited an  3!3 heterohexameric structure and contained one Rieske-type [2Fe-2S] cluster 10 
and one mononuclear iron per   subunit. In the presence of purified reductase (PhnA4) and 11 
ferredoxin (PhnA3) components, PhnII catalyzed the hydroxylation of salicylate to catechol 12 
with a maximal specific activity of 0.89 U/mg and showed an apparent Km for salicylate of 13 
1.1 ± 0.2  M. The hydroxylase exhibited similar activity levels with methylsalicylates and 14 
low activity with salicylate analogues bearing additional hydroxyl or electron-withdrawing 15 
substituents. PhnII converted anthranilate to 2-aminophenol and exhibited a relatively low 16 
affinity for this substrate (Km = 28 ± 6  M). 1-Hydroxy-2-naphthoate, which is an 17 
intermediate in phenanthrene degradation, was not hydroxylated by PhnII, but induced a high 18 
rate of uncoupled oxidation of NADH. It also exerted a strong competitive inhibition of 19 
salicylate hydroxylation, with a Ki of 0.68  M. The properties of this three-component 20 
hydroxylase are compared with those of analogous bacterial hydroxylases and discussed in 21 




Bacterial isolates belonging to the sphingomonad group have been shown to degrade a wide 2 
range of organic pollutants, including recalcitrant compounds such as chlorinated xenobiotics 3 
(16), dioxins (26) and polycyclic aromatic hydrocarbons (PAHs) (9, 18, 20, 32). The 4 
remarkable capabilities of this group of bacteria suggested that they might be useful for 5 
bioremediation purposes, and prompted studies on the identification of the catabolic enzymes 6 
involved. Independent genetic analyses on different PAH-degrading strains revealed that they 7 
contain a unique set of catabolic genes, often carried on a megaplasmid, which is probably 8 
responsible for their versatile metabolism (15, 20, 23). Extending over a 40-kb DNA region, 9 
the main catabolic gene cluster includes xyl genes involved in the catabolism of 10 
monoaromatics interspersed with genes predicted to function in the degradation of polycyclic 11 
substrates (designated as bph, nah, ahd or phn). This unique gene arrangement, which is 12 
remarkably conserved between strains of various origins, contrasts with that found in other 13 
degraders such as pseudomonads. In Sphingobium yanoikuyae B1, the biodegradation of 14 
naphthalene is thought to proceed through a pathway similar to that found in Pseudomonas 15 
species, with a first set of enzymes converting naphthalene to salicylate and a second set 16 
responsible for the conversion of salicylate to Krebs cycle intermediates (15). In this strain as 17 
in other sphingomonads, many of the gene products involved in this pathway have been 18 
identified based on sequence similarity with known Pseudomonas enzymes, but no 19 
counterpart was found for NahG which catalyzes the monohydroxylation of salicylate to 20 
catechol (30). In addition, the function of many genes in the catabolism of other PAHs 21 
remains to be elucidated. 22 
 Peculiar to sphingomonads is the occurrence of multiple copies of genes predicted to encode 23 
the terminal component of Rieske-type oxygenases (21, 23). Genes coding for two cognate 24 
electron carriers are generally found adjacent to such oxygenase-encoding genes in other 25 
 4 
bacteria degrading aromatic hydrocarbons, but it is not the case in sphingomonads. Rieske-1 
type oxygenases are known to catalyze the dihydroxylation of various aromatic compounds, 2 
and often initiate the oxidative biodegradation of pollutants. They constitute a large family of 3 
two or three component metalloenzymes the catalytic component of which is generally an 4 
heteromeric  3!3 hexamer containing one Rieske-type [2Fe-2S] cluster and one non-heme 5 
iron atom per   subunit. The enzyme responsible for the initial attack on PAHs has recently 6 
been identified in Sphingomonas CHY-1, a strain able to grow on chrysene as sole carbon 7 
source (9, 25). The oxygenase, called PhnI, is functionally associated with a NAD(P)H-8 
oxidoreductase (PhnA4) and a ferredoxin (PhnA3) in a three-component enzyme complex 9 
able to oxidize a wide range of 2- to 5-ring PAHs (13). Analysis of a knockout mutant 10 
demonstrated that PhnI was absolutely required for growth on PAHs, indicating that no other 11 
oxygenase could replace PhnI in the initial dihydroxylation of PAHs (9). Another oxygenase 12 
named PhnII, which catalyzes the C1-hydroxylation of salicylate to catechol has been 13 
identified in strain CHY-1. When overproduced in recombinant form in E. coli, PhnII 14 
required the co-expression of the ancillary proteins PhnA4 and PhnA3 for full activity, 15 
indicating that it is a three-component enzyme which shares electron carriers with PhnI (9). 16 
PhnII resembles salicylate 5-hydroxylase from Ralstonia sp. strain U2, which oxidizes 17 
salicylate to gentisate (31) but differs from salicylate 1-hydroxylases found in pseudomonads, 18 
which are monomeric flavoproteins (29). Interestingly, PhnII is also related to anthranilate 19 
dioxygenase from Burkholderia cepacia DBO1, a three-component enzyme that exclusively 20 
catalyses dioxygenation reactions (6). The occurrence of three-component salicylate 1-21 
hydroxylases was first reported by Pinyakong et al., in Sphingobium sp. strain P2, a 22 
phenanthrene degrading strain (22). This strain synthesized three isoenzymes homologous to 23 
PhnII, which showed different specificities toward substituted salicylates. Sequence 24 
comparisons using BLAST indicated that PhnII showed substantial similarities with one 25 
 5 
hydroxylase from strain P2 (83% and 71% identities between the   and ! subunits, 1 
respectively) but only moderate similarities with the other two P2 enzymes (>51% and >45% 2 
identities). Such comparisons of protein sequences did not reveal any clue that would explain 3 
the differences in selectivity between these enzymes. In Sphingobium yanoikuyae B1, indirect 4 
evidence indicated that an analogous hydroxylase catalyzed both salicylate hydroxylation and 5 
conversion of 1-hydroxy-2-naphthoate to 1.2-dihydroxynaphthalene (7). The latter reaction is 6 
a key step in the biodegradation of phenanthrene by Gram negative bacteria.  7 
 So far, none of the three-component hydroxylases considered above has been purified, and 8 
therefore biochemical and catalytic data on this important class of enzymes are lacking. Here, 9 
we have purified the PhnII enzyme to near homogeneity and have investigated the kinetics of 10 
the catalytic hydroxylation of salicylate and several analogues. We also show that 1-hydroxy-11 
2-naphthoate is not a substrate but triggers NADH oxidation at a high rate in a totally 12 
uncoupled reaction. This reaction might inhibit PAH degradation by sphingomonads when 13 
phenanthrene is an abundant substrate.   14 
 15 
MATERIALS AND METHODS 16 
Bacterial strains, plasmids and growth conditions 17 
Strains of Escherichia coli and Pseudomonas putida, and plasmids used for gene 18 
overexpression, as well as general culture conditions, have been previously described (9). 19 
Plasmid pVEHD11 carrying the phnA1bA2b coding sequence fused to a 5’-extension coding 20 
for a Histag, was constructed in two steps. A NdeI-BamHI fragment carrying the two genes of 21 
interest was isolated from plasmid pDAB11 (9) and subcloned into pET15b (Novagen) to 22 
give pEHD11. The insert was then extracted from pEHD11 as a XbaI fragment and cloned 23 
into pVLT31 (8). A plasmid carrying phnA1bA2b in the right orientation with respect to the 24 
Ptac promoter  was selected and designated pVEHD11. Overproduction of ht-PhnII was 25 
 6 
performed either in E. coli BL21(DE3) carrying pEHD11 or in P. putida KT2442 carrying 1 
pVEHD11. Overproduction of ht-PhnA3, ht-PhnA4 and ht-RedB356 that were used as electron 2 
carriers for ht-PhnII in oxygenase assays has been previously described (13).  3 
Large-scale cultures of strain KT2442(pVEHD11) were grown on Luria-Bertani rich medium 4 
in a 12-L fermentor as previously described (13). Expression of the recombinant oxygenase 5 
was induced at 25°C with 0.2 mM IPTG, and incubation was prolonged for 20 h before 6 
harvesting the culture by centrifugation. The bacterial pellet was washed with 50 mM Tris-7 
HCl buffer (pH 7.5) and kept frozen until use.  8 
 9 
Purification of the oxygenase component PhnII 10 
All purification procedures were carried out under argon, using buffers equilibrated for at 11 
least 24 h in a glove box maintained under anoxic conditions (O2 < 2 ppm, Jacomex, France). 12 
The temperature was kept at 0-4 °C except when otherwise indicated. A crude extract was 13 
prepared by thawing the bacterial pellet (100 g) in two volumes of lysis buffer (50 mM Tris-14 
HCl, pH 7.5) by volume, followed by lysozyme treatment (0.5 mg/ml) for 15 min at 30°C. 15 
The suspension was then subjected to ultrasonication for a total time of 10 min including 5 16 
min of pause at 75% of maximal intensity using a Vibra Cell apparatus run in pulse mode at 5 17 
s/pulse (Fisher Bioblock Scientific, Illkirch, France). The lysate was centrifuged at 12,000 g 18 
for 30 min, and the resulting cell extract was diluted two-fold with TG buffer (25 mM Tris-19 
HCl, pH 7.5, containing 5% glycerol and 2 mM  -mercaptoethanol) and applied to two 40-ml 20 
columns of DEAE-cellulose (DE52, Whatman) equilibrated with TG buffer. After washing 21 
the columns with four bed volumes of the same buffer, the oxygenase was eluted as a brown 22 
band with buffered 0.3 M NaCl. The eluate (about 50 ml) was immediately applied to a small 23 
column (7 ml) of immobilized metal affinity chromatography (IMAC) resin loaded with Co
2+
 24 
(TALON, BD Biosciences Ozyme, France). The column was washed successively with 8 bed 25 
 7 
volumes of TG buffer containing 0.5 M NaCl and 5 bed volumes of the same buffer 1 
supplemented with 20 mM imidazole and 1 mM salicylate. A brown protein fraction was then 2 
eluted with TG buffer containing 0.15 M imidazole and 1 mM salicylate.  A portion of the 3 
preparation (1.3 ml containing about 40 mg of protein) was applied to a 1.5   60 cm column 4 
of Superdex SD200 equilibrated in TG buffer containing 0.1 M NaCl and eluted at a rate of 5 
0.43 ml/min.  The purified protein fraction was concentrated onto a small column of DEAE-6 
cellulose, eluted in about 1 ml of TG buffer containing 0.3 M NaCl, and frozen as pellets in 7 
liquid nitrogen. This preparation, designated ht-PhnII, was judged to be at least 95% pure by 8 
SDS-PAGE (Fig 1).  9 
 10 
Purification of other proteins 11 
The ferredoxin (ht-PhnA3) from strain CHY-1 and the reductase component of the biphenyl 12 
dioxygenae from C. testosteroni B-356 (ht-RedB356) were purified as previously described 13 
(13). The catechol 2,3-dioxygenase from Pseudomonas putida mt2 (XylE) was purified 14 
according to a published procedure (11).  15 
 16 
Enzyme assays 17 
Salicylate hydroxylase activity was determined using three different assays.  In the coupled 18 
assay, the formation of catechol from salicylate was coupled to ring cleavage by catechol 2,3-19 
dioxygenase (XylE). Each reaction mixture contained 0.1  M ht-PhnII, 1.5 or 3  M ht-20 
PhnA3, 0.3  M ht-RedB356, 0.03  M XylE, 0.2 mM NADH and 0.5 mM salicylate in 50 mM 21 
potassium phosphate buffer, pH 7.0. Reactions were carried out at 30°C in quartz cuvettes, 22 
and initiated by the injection of a 100-fold concentrated solution of the protein mixture with a 23 
gas-tight syringe. The protein mixture was prepared 30 min before starting the assays and 24 
kept on ice under argon in phosphate buffer containing 1 mM dithiothreitol, 0.05 mM ferrous 25 
 8 
ammonium sulfate and 10% glycerol. The absorption at 376 nm was recorded at 0.1-s 1 
intervals over 1 min with a HP8452 spectrophotometer (Agilent Technologies, Les Ulis, 2 
France). The enzyme activity was calculated from the initial linear portion of the time course, 3 




 for 2-hydroxymuconate semi-aldehyde 4 
(11). Assuming that each molecule of the latter product resulted from the oxidation of one 5 
molecule of catechol, one unit of activity was defined as the amount of enzyme that converted 6 
one micromole of salicylate to catechol per minute.   7 
The enzyme activity was also measured by recording NADH oxidation at 340 nm, and 8 




. The protein mixture used had 9 
the same composition as that described above, except that XylE was omitted. Alternatively, 10 
the oxygenase activity was determined by monitoring O2 uptake using a Clark-type O2 11 
electrode under conditions essentially similar to those previously described (13). Assays 12 
contained NADH at an initial concentration of 0.4 mM. After approximately 60 nmol O2 had 13 
been consumed, 300 U of liver catalase (Sigma-Aldrich) was added to estimate the amount of 14 
H2O2 formed during the assay. In some cases, 0.6 ml of reaction mixture was immediately 15 
withdrawn, and acidified with 0.1 % acetic acid. After centrifugation and filtration, samples 16 
were analyzed by HPLC to quantify the catechols formed as described below.  17 
 18 
Steady-state kinetics 19 
Sets of salicylate hydroxylase assays were carried out at substrate concentrations that were 20 
varied over a 0.5-100  M range. Activity was measured in the XylE-coupled assay as 21 
described above. All assays were performed in duplicates, and at least 12 concentrations were 22 
tested. For titration of the hydroxylase with anthranilate, enzyme activity was measured by 23 
monitoring NADH oxidation at 340 nm. Assays were performed for substrate concentrations 24 
ranging between 5 and 500  M. Oxidation rates were calculated using an absorption 25 
 9 




 to take into account the absorbance of anthranilate 1 
at 340 nm. Plots of the initial reaction rate versus substrate concentration were fitted to the 2 
Michaelis-Menten equation using the curve fit option of Kaleidagraph (Synergy Software). 3 
Only curve fits showing correlation coefficients better than 0.98 were considered. 4 
 5 
Chemical identification and quantification of the enzymatic products 6 
The oxidation products generated by PhnII were analyzed by GC-MS. Samples were 7 
derivatized with bis(trimethysilyl)trifluoroacetamide : trimethylchlorosilane (99:1) from 8 
Supelco (Sigma-Aldrich), prior to analysis using a HP6890 gas chromatograph coupled to a 9 
HP5973 mass spectrometer (Agilent Technologies). Operating conditions were as previously 10 
described (12), and mass spectrum acquisitions were carried out in the scan mode. 11 
Concentrations of catechol and methylcatechols formed by salicylate 1-hydroxylase were 12 
determined by HPLC using a Kontron system equipped with a F430 UV detector. Samples 13 
(0.1 ml) were injected onto a 4 150-mm C8 reverse-phase column (Zorbax, Agilent 14 
Technologies) run at 0.8 ml/min. The column was eluted with a linear gradient of 0 to 50% 15 
acetonitrile in water over 15 min. Detection was carried out at 276 nm. Calibration curves 16 
were generated by injecting known amounts of 3-methyl-, 4-methyl- or unsubstituted 17 
catechol.  18 
  19 
Determination of the iron content of proteins 20 
To extract iron from proteins, samples (150  l) were treated with 2.5 N HCl for 30 min at 21 
95°C, then diluted with 135  l of ultrapure water. Iron was assayed in triplicate as a complex 22 
with bathophenanthroline by absorbance measurement at 536 nm (2). A calibration curve was 23 
generated by diluting a standard solution of ferric nitrate containing 1g/L Fe (Merck). 24 
 25 
 10 
Protein analyses 1 
Routine protein determinations were performed using the Bradford assay (4), or the 2 
bicinchoninic acid reagent kit (Pierce) using bovine serum albumin as a standard. A modified 3 
microbiuret assay was used for measuring the protein content of purified preparations of ht-4 
PhnA3 and ht-PhnII  (19). SDS-PAGE on mini-slab gels was performed as previously 5 
described (14). The molecular mass of purified ht-PhnII was determined by size-exclusion 6 
chromatography on a column (1.5 x 60 cm) of Superdex SD200 (Amersham Biosciences). 7 
The column was run at a flow rate of 0.2 ml/min and calibrated with the following protein 8 
markers: Ferritin (443 kDa), catalase (240 kDa), aldolase (150 kDa), bovine serum albumin 9 
(67 kDa), ovalbumin (43 kDa) and myoglobin (17 kDa), all from Sigma-Aldrich. 10 
 11 
EPR analysis 12 
Purified ht-PhnII was adjusted to 30  M in 25 mM Tris-HCl, pH 7.5 containing 5% glycerol 13 
and reduced with 1 mM dithionite. The EPR spectrum was recorded at 4 K as previously 14 




Purification and biochemical properties of salicylate 1-hydroxylase from strain CHY-1 2 
The structural genes encoding the hydroxylase were cloned into pET15b in order to produce 3 
the enzyme with a His-tag fused at the N-terminus of the large subunit. When introduced into 4 
an appropriate E. coli overexpression strain, two polypeptides of the expected sizes were 5 
detected in the cell extract by SDS-PAGE, but the enzyme was essentially inactive. Transfer 6 
of the genes into plasmid pVLT31 under the Ptac promoter resulted in an efficient expression 7 
system producing active enzyme in both E. coli and P. putida. The latter organism was 8 
preferred as a host to overproduce the recombinant enzyme because it consistently afforded 9 
better purification yields compared to E. coli. The hydroxylase was purified under anoxic 10 
conditions using a three-step procedure as described under Materials and Methods, yielding a 11 
protein preparation that was judged more than  95 % pure based on SDS-PAGE (Fig. 1). It 12 
consisted of two polypeptides with apparent Mr of 47,000 and 21,000. We observed that the 13 
enzyme activity fell dramatically upon IMAC chromatography, most likely because the 14 
enzyme lost a good part of its active site Fe(II) ion. This loss of activity could be prevented by 15 
supplementing buffers with 1 mM salicylate, while ethanol or isopropanol had no protecting 16 
effect. After the last  purification step, maximal activity was obtained by incubating the 17 
protein preparation for 1 h at 4°C with 0.1 mM ferrous ammonium sulfate. The purified 18 
enzyme exhibited a specific activity of 0.89 U/mg in a coupled assay in which the catechol 19 
formed by the hydroxylase was oxidized to 2-hydroxymuconic acid semialdehyde by catechol 20 
dioxygenase (see Methods). The molecular mass of the hydroxylase as deduced from gel 21 
filtration experiments was 190 kDa, consistent with an  3!3 hexameric structure. The enzyme 22 
exhibited a broad absorbance maximum at 456 nm with a shoulder around 530 nm, which is 23 
typical for proteins containing Rieske-type [2Fe-2S] clusters. The occurrence of such clusters 24 
in the protein was confirmed by EPR analysis of a dithionite-reduced sample, which gave a 25 
 12 
rhombic signal centered around g = 1.91 (data not shown). The iron content of the enzyme 1 
was calculated to be 8.52 ± 0.21 Fe/mol based on chemical assay, which is close to the 2 
theoretical value for an  3!3 hexamer containing one [2Fe-2S] cluster and one non-heme iron 3 
per   subunit. Overall, the salicylate hydroxylase from strain CHY-1 exhibited biochemical 4 
properties similar to those of classical Rieske-type dioxygenases that catalyze the 5 
dihydroxylation of various aromatic hydrocarbons (5). 6 
 7 
Catalytic properties and substrate specificity 8 
The activity of the purified ht-PhnII oxygenase required ancillary proteins PhnA4 and PhnA3 9 
to transfer electrons derived from NADH oxidation to the enzyme active site. The dependence 10 
of the enzyme complex activity on the concentration of each electron carrier was studied in 11 
assays where their molar ratio relative to the oxygenase component was independently varied. 12 
While half-saturation was reached at a reductase-to-oxygenase ratio close to 0.5, a much 13 
higher relative concentration of ferredoxin ht-PhnA3 was needed to reach maximum activity. 14 
At the highest protein ratio tested (about 200-fold molar excess of ferredoxin), the enzyme 15 
activity was not fully saturated. Nevertheless, in the assays described herein this ratio was set 16 
at 30 or below, in order to prevent excessive substrate-independent NADH oxidation by the 17 
enzyme complex. Also, the reductase component of the biphenyl dioxygenase from 18 
Comamonas testosteroni, ht-REDB356, was substituted for PhnA4 in most assays because the 19 
reductase from strain CHY-1 proved to be an unstable protein (13). No loss of hydroxylase 20 
activity was observed as a result of this replacement.  21 
The substrate specificity of the hydroxylase toward various salicylate analogues was first 22 
determined by NADH oxidation assays (Table 1). At the end of each assay, the product 23 
formed was extracted with ethyl acetate, and analyzed by GC-MS. The enzyme showed high 24 
levels of activity with all the methylsalicylates tested, with a preference for 4-25 
 13 
methylsalicylate. Analogues bearing a substituent with a high electron withdrawing effect, 1 
like 5-chloro- and 5-nitrosalicylate were poor substrates. 2,4- and 2,6-Dihydroxybenzoates 2 
were converted to products identified as trihydroxybenzenes by GC-MS, but gentisate (2,5-3 
dihydroxybenzoate) gave no detectable product.  These three compounds yielded relatively 4 
small amounts of product (if any), which did not correlate with the high NADH oxidation 5 
rates observed, indicating that the catalytic reaction was uncoupled. Anthranilate also gave 6 
rise to substantial NADH oxidation while producing little 2-aminophenol as the only 7 
detectable product. When 1-hydroxy-2-naphthoate and 2-hydroxy-1-naphthoate were 8 
provided as substrates, NADH oxidation was the highest but no product was formed, 9 
suggesting that the reaction was fully uncoupled. To further investigate the catalytic 10 
properties of strain CHY-1 salicylate 1-hydroxylase, enzyme reactions were monitored by 11 
amperometric measurements of O2 uptake. 12 
 13 
Uncoupled reactions catalyzed by salicylate 1-hydroxylase 14 
Substrate-dependent oxygen uptake by CHY-1 hydroxylase as well as hydrogen peroxide 15 
formation during the assays were measured for several salicylate analogues (Table 2). When 16 
possible, catechol products were quantified in order to determine the coupling efficiency 17 
between oxygen consumption and catechol formation. A fairly good coupling was observed 18 
upon enzymatic oxidation of salicylate and methylsalicylates, although a small proportion of 19 
the O2 consumed was reduced to H2O2. As the enzyme also formed hydrogen peroxide in the 20 
absence of substrate (data not shown), we assume that this low activity might result from an 21 
autooxidation of the ht-PhnA3 ferredoxin, as previously observed with a similar enzyme 22 
system (13). When anthranilate and nitrosalicylate were used as substrates, a greater 23 
proportion of the oxygen consumed was converted to peroxide. The two hydroxynaphthoate 24 
molecules gave rise to high rates of oxygen uptake with no product formation. HPLC 25 
 14 
measurements at the end of the reaction revealed that the substrate concentration had not 1 
significantly decreased. These results indicated that both hydroxynaphthoates triggered a 2 
highly uncoupled enzymatic reaction, as confirmed by the high proportion of oxygen 3 
recovered as hydrogen peroxide. Some of the reactions catalyzed by the hydroxylase from 4 
strain CHY-1 are illustrated in figure 2. 5 
 6 
Steady-state kinetics  7 
Steady-state rates of salicylate hydroxylation by the purified enzyme were measured at 8 
substrate concentrations in the range 0.5 to 100  M. The XylE-coupled assay was used to 9 
monitor the reaction because it directly measured the rate of product formation, whereas other 10 
assays might have introduced a bias due to the imperfect coupling of the reaction.  The 11 
enzyme titration gave data that could be fitted by the Michaelis function, from which an 12 
apparent Km of 1.10 ± 0.2  M was calculated.  This value remained constant when the ht-13 
PhnA3/ht-PhnII molar ratio was varied. On the other hand, the apparent turnover number of 14 
the hydroxylase was found to depend on this ratio, and to vary from one enzyme preparation 15 
to another, probably as a function of the iron content of the enzyme.  Catalytic velocity ranged  16 
between 0.73 ± 0.04 s
-1
 at a ratio of 15 for one preparation, and 2.9 s
-1
 at a ratio of 30 for 17 
another preparation. Inhibition of the hydroxylase activity was observed at high salicylate 18 
concentration, reaching 30% at 0.5 mM and 51% at 1 mM. The kinetic parameters of the 19 
enzyme towards anthranilate were also examined at substrate concentrations that were varied 20 
between  5 and 400  M. Steady-state rates were determined using NADH oxidation assays. 21 
PhnII exhibited an almost 30-fold higher Km (28 ± 6  M) for this substrate compared to 22 
salicylate, whereas its Vmax taken as the NADH oxidation rate, was very similar for both 23 
substrates. However, since NADH oxidation was poorly coupled to anthranilate 24 
 15 
hydroxylation (Table 2), the actual rate of substrate hydroxylation was lower in the case of 1 
anthranilate. 2 
 3 
Inhibition of salicylate  hydroxylation by 1-hydroxy 2-naphthoate 4 
The bacterial degradation of phenanthrene leads to the intermediate metabolite 1-hydroxy 2-5 
naphthoate, which in gram-negative species like Pseudomonas sp., is thought to be converted 6 
to 1,2-dihydroxynaphthalene by the same enzyme that hydroxylates salicylate (1). Since 1-7 
hydroxy 2-naphthoate was not a substrate of the hydroxylase studied herein, and caused 8 
uncoupling of the reaction, we examined whether this compound would inhibit salicylate 9 
hydroxylation in vitro. To this end, we performed salicylate titration curves at various 10 
concentrations of 1-hydroxy 2-naphthoate (Fig. 3A). Results showed that the hydroxylation 11 
reaction was strongly inhibited through a mechanism that appeared to be competitive. A plot 12 
of Km /Vmax values versus inhibitor concentration gave a straight line, which allowed to 13 
calculate an inhibition constant of 0.68  M (Fig. 3B). 14 
 15 
DISCUSSION 16 
In this work, we describe the first characterization of a three-component salicylate 1-17 
hydroxylase, an enzyme that appears to be present only in PAH-degrading strains of the 18 
sphingomonad group. The oxygenase component of the enzyme exhibited biochemical 19 
properties and a co-factor content very similar to that of typical ring-hydroxylating 20 
dioxygenases catalyzing the dihydroxylation of various aromatic substrates (5). In addition, 21 
the PhnII protein shows significant sequence similarity with anthranilate dioxygenase from 22 
Burkholderia cepacia DBO1 (52% and 38% identity for the   and ! subunits, respectively; 23 
(6)), which converts anthranilate to catechol. Nevertheless, PhnII exclusively catalyzes 24 
monohydroxylations as exemplified by the conversion of anthranilate to 2-aminophenol. 25 
 16 
Phylogenetic analyses have previously shown that the oxygenase components of anthranilate 1 
dioxygenase from strain DBO1 and of salicylate 1-hydroxylases from sphingomonads 2 
(including PhnII) form a distinct group of enzymes, together with halobenzoate dioxygenases 3 
and salicylate 5-hydroxylase (6). Curiously, this group includes enzymes that function only as 4 
dioxygenases on the one hand, or as monohydroxylases on the other, and which all use 5 
substituted benzoates as substrates.  This observation raises questions about the structural 6 
features that determine whether an enzyme functions as a mono- or a dioxygenase.  Such a 7 
question might be addressed in experiments where a monohydroxylase  is modified to acquire 8 
the ability to catalyze dihydroxylations through site-directed mutagenesis of residues 9 
predicted to be at the enzyme active site. 10 
In in vitro assays, the catalytic activity of the hydroxylase was highly dependent on the molar 11 
ratio of the ferredoxin (PhnA3) and oxygenase (PhnII) components, half-saturation of the 12 
activity occurring for an approx. 200-fold excess of PhnA3. A similar observation was made 13 
with other three-component oxygenases, including the naphthalene dioxygenase (PhnI) from 14 
strain CHY-1 (13). However, in the latter case, half-saturation was achieved with a 14-fold 15 
excess of PhnA3, suggesting that the ferredoxin has a different affinity for the PhnI and PhnII 16 
oxygenases. This difference might have physiological significance inasmuch as the two 17 
oxygenases might compete for the same ferredoxin in vivo. Indeed, a single ferredoxin-18 
encoding gene homologous to phnA3 was identified in the catabolic cluster responsible for 19 
aromatic hydrocarbon degradation in three sphingomonads (15, 20, 23). In vivo, the 20 
ferredoxin requirement is certainly not as high as in vitro, because the high protein 21 
concentration of the cytosolic compartment probably favors ferredoxin oxygenase 22 
interactions. 23 
The three-component salicylate hydroxylase from strain CHY-1 has a low apparent Michaelis 24 
constant for its substrate, similar to that reported for counterparts of the flavoprotein-type 25 
 17 
found in Pseudomonas species (1.72-1.9  M; (1, 29)). The specific activity of the two types 1 
of enzymes is also of the same order (0.89 versus 0.27 U/mg for the P.putida enzyme; (1)), 2 
although direct comparison is difficult because the in vitro activity of the CHY-1 enzyme is 3 
strongly dependent on the ferredoxin/oxygenase molar ratio. Ht-PhnII appeared to be almost 4 
as active on methylsalicylates as on salicylate. This result is consistent with our finding that 5 
the aromatic ring-hydroxylating dioxygenase responsible for the initial attack on PAHs in 6 
CHY-1 can oxidize several methyl- and dimethylnaphthalenes (unpublished results), which 7 
are then predicted to be further oxidized to methylsalicylates. Ht-PhnII also hydroxylated 8 
salicylates with chlorine, nitro and hydroxyl substituents although at slower rates. A broad 9 
substrate specificity was also observed for the two flavoprotein hydroxylases from 10 
Pseudomonas stutzeri AN10 (3) and the three-component hydroxylases from Sphingobium P2 11 
(22). However, enzyme activity appeared to be dependent on the nature of the substituent 12 
group with an order of preference as follows : CH3 > Cl > NO3 > OH. This can be clearly seen 13 
by comparing the hydroxylase activity of ht-PhnII on salicylate analogues bearing either one 14 
of these groups in the C5 position (Table 1). In this respect, the 5-hydroxysalicylate or 15 
gentisate was not oxidized by ht-PhnII, whereas the isomers bearing an hydroxyl in the C4 or 16 
C6 position were hydroxylated. This finding indicates that a polar substituent in the C5 17 
position of the ring prevents productive interaction of the substrate at the enzyme active site, 18 
possibly because the substrate binding pocket has a hydrophobic character that hinders access 19 
of gentisate. Anthranilate was a poor substrate for ht-PhnII as indicated by the uncoupling of 20 
the hydroxylation reaction and the relatively high Km of the enzyme for this substrate. In 21 
comparison, the Km of anthranilate dioxygenase for anthranilate has been estimated to be 22 
about 1  M (10).  23 
The hydroxylation of anthranilate, as did that of other poor substrates, gave rise to a 24 
significant uncoupling of the reaction resulting in the formation of hydrogen peroxide. Such a 25 
 18 
side reaction has been observed for enzymes with similar structures that function as 1 
dioxygenases (13, 17) and seems to be a consequence of the catalytic mechanism of this type 2 
of enzyme (27, 28). Indeed, it has been observed that in naphthalene dioxygenase, substrate 3 
binding to the active site increases the affinity of the enzyme for oxygen (28). Such a 4 
mechanism might explain the high rate of substrate-induced reduction of oxygen to peroxide 5 
catalyzed by PhnII in the presence of pseudo-substrates such as hydroxynaphthoate.  6 
Interestingly, salicylate hydroxylases of the flavoenzyme type, which have a different 7 
catalytic mechanism, were also found to catalyze uncoupled reactions when incubated with 8 
certain salicylate analogues such as benzoate (24).    9 
Unlike the flavoprotein hydroxylase from P. putida (1), the enzyme from CHY-1 was unable 10 
to hydroxylate 1-hydroxy-2-naphthoate, a metabolite that is produced in the catabolic 11 
pathway of phenanthrene. Moreover, we bring evidence that this metabolite causes inhibition 12 
of salicylate hydroxylation, which might be deleterious to bacterial cells growing on PAHs. 13 
Indeed, salicylate is an intermediate in the degradation of several PAHs including 14 
naphthalene, anthracene, phenanthrene and fluorene, and its hydroxylation might be a 15 
bottleneck if subjected to metabolic inhibition. Such an inhibition could be circumvented in 16 
vivo if an enzyme oxidizes 1-hydroxy 2-naphthoate and maintains its concentration to a level 17 
low enough to prevent inhibition of PhnII, or if another salicylate hydroxylase functionally 18 
substitutes for PhnII. In the phenanthrene-degrading strain Sphingobium P2, three isoenzymes 19 
have been shown to catalyze salicylate hydroxylation (22) and counterparts were identified in 20 
two other sphingomonads from the analysis of catabolic genes (15, 23). In S. yanoikuyae B1, 21 
the hydroxylase encoded by bphA1cA2c, which shares high sequence similarities with PhnII 22 
(  and ! subunits show 79% and 66%  identities, respectively) has been proposed to catalyze 23 
hydroxylation of both salicylate and 1-hydroxy 2-naphthoate, as deduced from the analysis of 24 
a bphA1c knockout mutant strain (7). This mutant lost the ability to grow on salicylate and 25 
 19 
naphthalene, and accumulated 1-hydroxy 2-naphthoate when incubated with phenanthrene. 1 
However, the ability of the enzyme to catalyze the conversion of 1-hydroxy 2-naphthoate to 2 
1,2-dihydroxynaphthalene has not been clearly demonstrated. Besides, the latter study 3 
indicates that the bphA1c product is required for hydroxylation of salicylate, implying that 4 
this enzyme could not be replaced by anyone of the two other isoenzymes present in the 5 
bacterium. Hence, the physiological function and raison d’être of multiple copies of three-6 
component hydroxylases in the catabolism of PAHs by sphingomonads remain to be 7 
elucidated. Also, further work is needed to identify unambiguously in sphingomonads the 8 
enzyme responsible for the hydroxylation of 1-hydroxy 2-naphthoate, which is an essential 9 
step in phenanthrene catabolism.  10 
 11 
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  Enzyme activity 
b
 Products detected by GC-MS Identification of product 
 U.mg
-1
 % RT (min) Molecular mass  
      
Salicylate 0.578 100 8.87 254 catechol 
3-Methyl-salicylate 0.44 76 9.86 268 3-methyl catechol 
4-Methyl-salicylate 0.625 108 9.74 268 4-methyl catechol 
5-Methyl-salicylate 0.396 68.5 9.74 268 4-methyl catechol 
5-Chloro-salicylate 0.267 46 10.79 288 4-chloro catechol 
5-Nitro-salicylate 0.184 32 13.39 299 4-nitro catechol 





 12.14 322 3,5-dichlorocatechol 
2,4-dihydroxybenzoate 1.38 184 11.98 342 Trihydroxybenzene 
2,6-dihydroxybenzoate 0.326 44 11.34 342 Trihydroxybenzene 
Gentisate 1.21 162 - - no product 
1-hydroxy-2-naphthoate 1.35 179 - - no product 




Initial substrate concentration was 0.5 mM except for 1-hydroxy 2-naphthoate, 2-hydroxy 1-naphthoate (0.25 mM) and 5-nitrosalicylate (0.125 
mM). 
b 
Activities, expressed as  mol NADH.min-1.mg-1, are means of duplicate assays. Standard deviations are less than 5%. Values in italics are from 
a different set of assays and refer to an enzyme activity of 0.75 U.mg
-1
 with salicylate as substrate 
c 
Products were extracted with ethyl acetate after 2 min of reaction, and analyzed as trimethylsilyl derivates.  
 










    
Salicylate 0.757± 0.007 0.144 0.64 ± 0.04 
3-Methylsalicylate 0.711 ± 0.010 0.23 0.50 ± 0.01 
5-Methylsalicylate 0.659  ± 0.005 0.19 0.61 ± 0.01 
5-Chlorosalicylate 0.630 ± 0.025 0.19 nd 
5-Nitrosalicylate 0.416 ± 0.005 0.38 nd 
Anthranilate 0.630 ± 0.02 0.42 nd 
1-hydroxy-2-naphthoate 3.07  ± 0.01 0.70 No product 
2-hydroxy-1-naphthoate 8.56 ± 0.01 0.65 No product 
    
 3 
a 
Maximum velocities calculated from the initial O2 uptake rate taken during the first minute of the time course. 4 
The PhnA3/PhnII molar ratio was 30. 5 
 6 
b
 As determined from HPLC quantification after about 3 min. nd means not determined because no appropriate 7 




Figure legends 2 
Figure 1 : SDS-PAGE protein analysis during purification of recombinant ht-PhnII from strain KT2442 carrying 3 
pVEHD11. Lane 1, protein markers; lane 2, soluble cell-free extract; lane 3, DEAE column eluate; lane 4, IMAC 4 
column eluate; lane 5, dialyzed purified protein.  5 
Arrows point to the ! and " subunits of ht-PhnII. 6 
 7 
Figure 2 : Reactions catalyzed by the three-component hydroxylase from strain CHY-1.  8 
The scheme shows reaction products formed from (a) methylsalicylate, (b) anthranilate and (c) the 9 
pseudosubstrate 1-hydroy 2-naphthoate.  10 
 11 
Figure 3 : Inhibition of salicylate hydroxylation by 1-hydroxy 2-naphthoate.  12 
A) Steady state rates of salicylate hydroxylation were measured in the presence of 1-hydroxy 2-naphthoate at the 13 
following concentrations ( M): 0 (diamonds), 0.8 (filled circles), 2 (triangles), 5 (inversed triangles), 8 (open 14 
circles). Activities were measured in the coupled assay with an enzyme complex containing ht-PhnII and ht-15 
PhnA3 in a molar ratio of 1:15. Michaelis curve fits were adjusted to the data points as described in Methods. B) 16 
Plot of Km/Vmax versus  inhibitor concentration. 17 
 18 
 19 
Fig.1, Jouanneau et al., 2007
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Fig. 3, Jouanneau et al., 2007
